Active Ingredient: ACECLIDINE HYDROCHLORIDE
Proprietary Name: VIZZ
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: EQ 1.44% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218585
Product Number: 001
Approval Date: Jul 31, 2025
Applicant Holder Full Name: LENZ THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information